HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis

NCT00932971 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: PEG-IFN alfa-2a, Tenofovir
DRUG: PEG-IFN alfa-2a, placebo

Sponsor

HepNet Study House, German Liverfoundation

Collaborators

[object Object]
[object Object]
[object Object]